These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 15722794)
21. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract]. Yue C; Piao Y; Bai Y; Liu H; Zhang L Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206 [TBL] [Abstract][Full Text] [Related]
22. CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. Yatabe Y; Koga T; Mitsudomi T; Takahashi T J Pathol; 2004 Jun; 203(2):645-52. PubMed ID: 15141379 [TBL] [Abstract][Full Text] [Related]
23. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790 [TBL] [Abstract][Full Text] [Related]
24. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Strickland-Marmol LB; Khoor A; Livingston SK; Rojiani A Arch Pathol Lab Med; 2007 Nov; 131(11):1686-90. PubMed ID: 17979487 [TBL] [Abstract][Full Text] [Related]
25. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas. Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580 [TBL] [Abstract][Full Text] [Related]
26. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591 [TBL] [Abstract][Full Text] [Related]
27. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132 [TBL] [Abstract][Full Text] [Related]
28. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
29. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases. Tot T Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286 [TBL] [Abstract][Full Text] [Related]
30. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652 [TBL] [Abstract][Full Text] [Related]
31. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188 [TBL] [Abstract][Full Text] [Related]
32. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct. Lino-Silva LS; Salcedo-Hernández RA; García-Gómez MA; Ruiz-García EB; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Maldonado-Martínez HA Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052 [TBL] [Abstract][Full Text] [Related]
33. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
34. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas. Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509 [TBL] [Abstract][Full Text] [Related]
35. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Kende AI; Carr NJ; Sobin LH Histopathology; 2003 Feb; 42(2):137-40. PubMed ID: 12558745 [TBL] [Abstract][Full Text] [Related]
36. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2. Altree-Tacha D; Tyrrell J; Haas T Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907 [TBL] [Abstract][Full Text] [Related]
37. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum. Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817 [TBL] [Abstract][Full Text] [Related]
38. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980 [TBL] [Abstract][Full Text] [Related]
39. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer. Leite KRM; Mitteldorf CATS; Srougi M; Dall'Oglio MF; Antunes AA; Pontes J; Camara-Lopes LH Ann Diagn Pathol; 2008 Aug; 12(4):260-266. PubMed ID: 18620992 [TBL] [Abstract][Full Text] [Related]
40. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens. Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]